Material Safety Data Sheet- Lithium Bromide

===========================================================================

FMC -- LITHIUM BROMIDE ANHYDROUSFMC -- LITHIUM BROMIDE ANHYDROUS

MATERIAL SAFETY DATA SHEET

NSN: 681000N053547
Manufacturer's CAGE: 5D132
Part No. Indicator: APart Number/Trade Name: LITHIUM BROMIDE ANHYDROUS

===========================================================================
General Information
===========================================================================
Company's Name: FMC CORP
Company's P. O. Box: 795
Company's City: BESSEMER CITY
Company's State: NC
Company's Country: US
Company's Zip Code: 28016-0795
Company's Emerg Ph #: 704-629-5361;800-424-9300(CHEMTREC)
Company's Info Ph #: 704-868-5300
Record No. For Safety Entry: 001
Tot Safety Entries This Stk#: 001
Status: SMJ
Date MSDS Prepared: 03JUL91
Safety Data Review Date: 29SEP94
MSDS Serial Number: BVVPX
Hazard Characteristic Code: NK

===========================================================================
Ingredients/Identity Information
===========================================================================
Proprietary: NO
Ingredient: LITHIUM BROMIDE (ANHYDROUS)
Ingredient Sequence Number: 01
NIOSH (RTECS) Number: OJ5755000
CAS Number: 7550-35-8
OSHA PEL: N/K (FP N)
ACGIH TLV: N/K (FP N)
-------------------------------------
Proprietary: NO
Ingredient: SUPDAT:LEVELS LG ENOUGH TO PRDCE SIGNS OF SEV MATERNAL TOX.
WOMEN RECEIVING THERAPEUTIC LITHIUM CARBONATE (ING 3)
Ingredient Sequence Number: 02
NIOSH (RTECS) Number: 9999999ZZ
OSHA PEL: NOT APPLICABLE
ACGIH TLV: NOT APPLICABLE
-------------------------------------
Proprietary: NO
Ingredient: ING 2:TREATMENT AT TIME OF CONFINEMENT HAVE POTNTL FOR
DELIVERY OF FETUS W/POOR MUSCLE TONE, SLOWED HEART RATE & (ING 4)
Ingredient Sequence Number: 03
NIOSH (RTECS) Number: 9999999ZZ
OSHA PEL: NOT APPLICABLE
ACGIH TLV: NOT APPLICABLE
-------------------------------------
Proprietary: NO
Ingredient: ING 3:CYANOSIS. FULL RECOVERY USUALLY OCCURS W/IN 2-10 DAYS
POSTPARTUM. THERAPEUTIC & GREATER LEVELS OF LITHIUM (ING 5)
Ingredient Sequence Number: 04
NIOSH (RTECS) Number: 9999999ZZ
OSHA PEL: NOT APPLICABLE
ACGIH TLV: NOT APPLICABLE
-------------------------------------
Proprietary: NO
Ingredient: ING 4:MAY POSE RISK TO CONCEPTUS & POTNTL BENEFITS TO MOTHER
ARE WEIGHED CAREFULLY IN CLINICAL SITUATIONS. IT IS (ING 6)
Ingredient Sequence Number: 05
NIOSH (RTECS) Number: 9999999ZZ
OSHA PEL: NOT APPLICABLE
ACGIH TLV: NOT APPLICABLE
-------------------------------------
Proprietary: NO
Ingredient: ING 5:UNLIKELY THAT TYPICAL INDUS EXPOS TO LITHIUM WILL RSLT
IN BLOOD LEVELS SUFFICIENTLY HIGH TO PRDCE TOX IN (ING 7)
Ingredient Sequence Number: 06
NIOSH (RTECS) Number: 9999999ZZ
OSHA PEL: NOT APPLICABLE
ACGIH TLV: NOT APPLICABLE
-------------------------------------
Proprietary: NO
Ingredient: ING 6:EITHER ADULTS OR THEIR OFFSPRING.
Ingredient Sequence Number: 07
NIOSH (RTECS) Number: 9999999ZZ
OSHA PEL: NOT APPLICABLE
ACGIH TLV: NOT APPLICABLE
-------------------------------------
Proprietary: NO
Ingredient: FIRST AID PROC:ATTN. DO NOT INDUCE VOMIT/GIVE ANYTHING BY
MOUTH TO UNCON PERS. NOTES TO MD:EFTS OF ORAL OVEREXP (ING 9)
Ingredient Sequence Number: 08
NIOSH (RTECS) Number: 9999999ZZ
OSHA PEL: NOT APPLICABLE
ACGIH TLV: NOT APPLICABLE
-------------------------------------
Proprietary: NO
Ingredient: ING 8:TO LITHIUM ION ARE WELL DOCUMENTED IN MED LITERATURE.
LOW TOX IS ANTIC. IN SUCH CASES, STD PROTOCOLS FOR (ING 10)
Ingredient Sequence Number: 09
NIOSH (RTECS) Number: 9999999ZZ
OSHA PEL: NOT APPLICABLE
ACGIH TLV: NOT APPLICABLE
-------------------------------------
Proprietary: NO
Ingredient: ING 9:OVERDOSAGE IS SUGGESTED. TREATMENT IS OTHERWISE
SYMPTOMATIC & SUPPORTIVE.
Ingredient Sequence Number: 10
NIOSH (RTECS) Number: 9999999ZZ
OSHA PEL: NOT APPLICABLE
ACGIH TLV: NOT APPLICABLE

===========================================================================
Physical/Chemical Characteristics
===========================================================================
Appearance And Odor: WHITE GRANULAR SOLID; ODORLESS.
Boiling Point: 2309F,1265C
Melting Point: 1022F,550C
Vapor Pressure (MM Hg/70 F): N/A
Vapor Density (Air=1): N/A
Specific Gravity: 3.5
Evaporation Rate And Ref: NOT APPLICABLE
Solubility In Water: 61% BY WT @ 25C
Percent Volatiles By Volume: N/A
pH: 9

===========================================================================
Fire and Explosion Hazard Data
===========================================================================
Flash Point: NOT APPLICABLE
Lower Explosive Limit: N/A
Upper Explosive Limit: N/A
Extinguishing Media: ANY SUITABLE TO FIRE IN SURROUNDING AREA.
Special Fire Fighting Proc: USE NIOSH/MSHA APPROVED SCBA & FULL PROTECTIVE
EQUIPMENT (FP N).
Unusual Fire And Expl Hazrds: THIS PRODUCT IS NOT AN EXPLOSIVE.

===========================================================================
Reactivity Data
===========================================================================
Stability: YES
Cond To Avoid (Stability): CONTACT W/STRONG ACIDS.
Materials To Avoid: STRONG ACIDS.
Hazardous Decomp Products: NONE.
Hazardous Poly Occur: NO
Conditions To Avoid (Poly): NOT RELEVANT

===========================================================================
Health Hazard Data
===========================================================================
LD50-LC50 Mixture: LD50:(ORAL,RAT) >500 MG/KG.
Route Of Entry - Inhalation: NO
Route Of Entry - Skin: YES
Route Of Entry - Ingestion: NO
Health Haz Acute And Chronic: ACUTE:MAY IRRIT EYES & SKIN. INHAL/INGEST
CAN CAUSE VOMIT, NAUS, DIARR, DROW, MUSCULAR WEAK, LACK OF COORD, SKIN
ERUPTIONS/RASHES. CHRONIC:USE OF THIS PROD IN INDUS & COMMERCIAL
APPLICATIONS PRESENTS NO SIGNIFICANT TOX HAZ. SYMPS DESCRIBED BELOW ARE
BASED ON THERAPEUTIC APPLICATIONS WHERE RELATIVELY LG(EFTS OF OVEREXP)
Carcinogenicity - NTP: NO
Carcinogenicity - IARC: NO
Carcinogenicity - OSHA: NO
Explanation Carcinogenicity: NOT RELEVANT
Signs/Symptoms Of Overexp: HLTH HAZ:DOSES ARE TAKEN ORALLY BY MED
SUPERVISED PATIENTS. LITHIUM CARBONATE IS USED THERAPEUTICALLY AT
500-2000
MG/DAY ORAL DOSES FOR SPECIFIC MENTAL DISORDERS. THERAPEUTIC EFTS OCCUR AT
BLOOD LEVELS OF 2.8-8.3 MG LITHIUM PER LITER. MIN SIGNS OF TOX MAY ALSO
OCCUR AT THESE THERAPEUTIC LEVELS & INVOLVE (SUPP DATA)
Med Cond Aggravated By Exp: NO APPLICABLE INFORMATION WAS FOUND.
Emergency/First Aid Proc: EYES:FLUSH W/WATER FOR AT LST 15 MINS, LIFTING
UPPER & LOWER EYELIDS OCCAS. IF IRRIT OCCURS & PERSISTS, OBTAIN MED ATTN.
SKIN:WASH W/WATER. IF IRRIT OCCURS & PERSISTS, OBTAIN MED ATTN.
INHAL:REMOVE TO FRESH AIR. IF DISCOMFORT OCCURS & PERSISTS, OBTAIN MED
ATTN. INGEST:DRINK PLENTY OF WATER & INDUCE VOMIT BY TOUCHING BACK OF
THROAT W/FINGER/IF AVAIL, BY ADMIN SYRUP OF IPECAC. OBTAIN MED (ING 8)

===========================================================================
Precautions for Safe Handling and Use
===========================================================================
Steps If Matl Released/Spill: COLLECT SPILLS & PLACE IN A SUITABLE
CONTAINER.
Neutralizing Agent: NONE SPECIFIED BY MANUFACTURER.
Waste Disposal Method: DISPOSE OF WASTE ACCORDING TO FEDERAL EPA, STATE &
LOCAL REGULATIONS.
Precautions-Handling/Storing: AVOID CONTACT W/EYES, SKIN OR CLOTHING.
AVOID BREATHING DUST. KEEP AWAY FROM STRONG ACIDS. USE W/ADEQUATE
VENTILATION. KEEP CONTAINER CLOSED.
Other Precautions: PRECS TO BE TAKEN IN TRANSPORTATION:ISOLATE DAMAGED
CONTAINERS. TRANSPORTING TYPE PACKAGES:OPEN-HEAD DOT 17C/37A STEEL DRUM
W/EPOXY-COATED INTERIOR. DECONTAMINATION PROCS:WASH W/SOAP & WATER.

===========================================================================
Control Measures
===========================================================================
Respiratory Protection: WEAR A NIOSH/MSHA APPROVED RESPIRATOR WHEN
ADEQUATE VENTILATION IS NOT AVAILABLE.
Ventilation: USE W/ADEQUATE VENTILATION.
Protective Gloves: RUBBER GLOVES.
Eye Protection: ANSI APPROVED CHEM WORKERS GOGGS (FP N).
Other Protective Equipment: QUICK-DRENCH EYEWASH & SAFETY SHOWER.
Work Hygienic Practices: WASH THOROUGHLY AFTER HANDLING.
Suppl. Safety & Health Data: EFTS OF OVEREXP:PRIMARILY GI UPSET. INCR
DOSAGE CAN PRDCE TREMORS, DROW & UNSTEADY GAIT. SIGNS OF TOX RESOLVE
RAPIDLY ON CESSATION OF TREATMENT. PRLNG TREATMENT AT TOX LEVELS RSLT IN
DEHYDRATION, KIDNEY DMG, WT LOSS & THYROID DISTURBS. SOME STUDIES OF
PREGNANT MICE WERE ASSOC W/BIRTH DEFECTS BUT ONLY AT DOSE (ING 2)

===========================================================================
Transportation Data
===========================================================================

===========================================================================
Disposal Data
===========================================================================

===========================================================================
Label Data
===========================================================================
Label Required: YES
Technical Review Date: 05OCT94
Label Date: 28SEP94
Label Status: G
Common Name: LITHIUM BROMIDE ANHYDROUS
Chronic Hazard: NO
Signal Word: CAUTION!
Acute Health Hazard-Slight: X
Contact Hazard-Slight: X
Fire Hazard-None: X
Reactivity Hazard-None: X
Special Hazard Precautions: AVOID EYE & SKIN CONTACT. DO NOT BREATHE DUST.
ACUTE:MAY IRRITATE EYES & SKIN. INHALATION OR INGESTION CAN CAUSE VOMITING,
NAUSEA, DIARRHEA, DROWSINESS, MUSCULAR WEAKNESS, LACK OF COORDINATION, SKIN
ERUPTIONS OR RASHES. CHRONIC:USE OF THIS PRODUCT IN INDUSTRIAL & COMMERCIAL
APPLICATIONS PRESENTS NO SIGNIFICANT TOXICITY HAZARD.
Protect Eye: Y
Protect Skin: Y
Protect Respiratory: Y

Label Name: FMC CORP
Label P.O. Box: 795
Label City: BESSEMER CITY
Label State: NC
Label Zip Code: 28016-0795
Label Country: US

Label Emergency Number: 704-629-5361;800-424-9300(CHEMTREC)